At a glance
- Originator Cephalon France
- Class Antidepressants; Ethanolamines; Small molecules
- Mechanism of Action Beta adrenergic receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Major depressive disorder
Most Recent Events
- 26 Mar 2007 Discontinued - Phase-II for Depression in France (unspecified route)
- 23 Jul 2003 No development reported - Phase-II for Depression in France (unspecified route)
- 23 Nov 2000 Profile reviewed but no significant changes made